Company news
Scancell Holdings Plc (LSE:SCLP) news
Scancell Holdings Plc news releases on 6ix. Latest, Jul 22, 2020: Result of Placing and Notice of General Meeting
Press releases — page 4
Result of Placing and Notice of General Meeting
July 22, 2020
Proposed Capital Raise
July 22, 2020
New publication highlights potential of Modi-1
June 24, 2020
Publication highlights potential of AvidiMab
June 12, 2020
Director salaries and award of share options
May 1, 2020
Scancell: Development of vaccine against COVID-19
April 24, 2020
Scancell to Present at Three Research Conferences
March 3, 2020
SCIB1 IND Application Approved
February 3, 2020
Third agreement signed for antibody platform
January 20, 2020
Director's Dealings
December 17, 2019
Second agreement signed for AvidiMab platform
December 16, 2019
New European Moditope patent allowed for grant
November 20, 2019
Posters at Cancer Immunotherapy Conference
September 26, 2019
First Collaboration Agreement for AvidiMab
September 4, 2019
Final Results for the year ended 30 April 2019
August 20, 2019
Update on the SCIB1 Phase 2 clinical trial
August 19, 2019
H1 2019 Business Update
July 1, 2019
Board Appointment
June 18, 2019
Share Subscription and Issue of Equity to Vulpes
June 13, 2019
Scancell and CRUK provide an update on SCIB2
May 20, 2019
Clinical Advisory Board and Update on Modi-1
May 10, 2019
UK approval to start SCIB1 Phase 2 trial
April 25, 2019
Japan patent for Moditope immunotherapy platform
April 8, 2019
Professor Lindy Durrant receives Waldenström award
March 21, 2019
Scancell strengthens IP portfolio
March 20, 2019
Update on Cancer Research UK's Grand Challenge
January 23, 2019
Appoints Heads of Research and Manufacturing
January 21, 2019
Scancell to Present at Two Conferences
November 12, 2018
Scancell to present at Proactive Investors Forum
November 1, 2018
Results of AGM
October 30, 2018
Identification of 2nd Moditope Cancer Vaccine
October 30, 2018
Update on SCIB1 Phase 2 Clinical Study
October 24, 2018
Final Results for the year ended 30 April 2018
September 25, 2018
Board Change
August 10, 2018
Agreement
August 9, 2018
Scancell exercises TriGrid commercial option
July 18, 2018
Grant of European patent for Moditope platform
May 23, 2018
Result of the Open Offer and PDMR Shareholdings
May 8, 2018
Result of Placing and Subscription and PDMR
April 18, 2018
Technology acquired from University of Nottingham
April 18, 2018
Proposed Placing, Subscription and Open Offer
April 18, 2018
Manufacturing agreement with The PolyPeptide Group
April 3, 2018
Scancell to present at the Calculus Investor Forum
February 16, 2018
Hardman Res. - Validating multiple opportunities
February 15, 2018
Collaboration agreement with ISA Pharmaceuticals
February 15, 2018
Publication highlights potential of SCIB1 therapy
February 12, 2018
European patent application allowed for grant
February 9, 2018
Scancell member of team shortlisted for CRUK award
February 8, 2018
Half-year Report
January 30, 2018
Scancell to collaborate with BioNTech
January 9, 2018